Ionis Pharmaceuticals, Inc. (IONS)
54.21
-1.44
(-2.59%)
USD |
NASDAQ |
Sep 11, 16:00
54.41
+0.20
(+0.37%)
After-Hours: 20:00
Ionis Pharmaceuticals Market Cap : 8.979B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 8.979B |
| September 10, 2026 | 9.218B |
| September 09, 2026 | 9.279B |
| September 08, 2026 | 9.393B |
| September 04, 2026 | 9.622B |
| September 03, 2026 | 9.628B |
| September 02, 2026 | 10.16B |
| September 01, 2026 | 9.918B |
| August 31, 2026 | 9.998B |
| August 28, 2026 | 10.11B |
| August 27, 2026 | 10.34B |
| August 26, 2026 | 10.49B |
| August 25, 2026 | 10.53B |
| August 24, 2026 | 10.28B |
| August 21, 2026 | 9.895B |
| August 20, 2026 | 9.733B |
| August 19, 2026 | 10.07B |
| August 18, 2026 | 9.875B |
| August 17, 2026 | 9.711B |
| August 14, 2026 | 9.481B |
| August 13, 2026 | 9.254B |
| August 12, 2026 | 9.363B |
| August 11, 2026 | 9.180B |
| August 10, 2026 | 9.431B |
| August 07, 2026 | 9.368B |
| Date | Value |
|---|---|
| August 06, 2026 | 9.026B |
| August 05, 2026 | 8.976B |
| August 04, 2026 | 9.122B |
| August 03, 2026 | 9.026B |
| July 31, 2026 | 8.575B |
| July 30, 2026 | 8.825B |
| July 29, 2026 | 8.951B |
| July 28, 2026 | 9.160B |
| July 27, 2026 | 9.269B |
| July 24, 2026 | 9.382B |
| July 23, 2026 | 9.269B |
| July 22, 2026 | 8.960B |
| July 21, 2026 | 8.858B |
| July 20, 2026 | 8.785B |
| July 17, 2026 | 9.023B |
| July 16, 2026 | 9.067B |
| July 15, 2026 | 9.080B |
| July 14, 2026 | 9.113B |
| July 13, 2026 | 9.415B |
| July 10, 2026 | 9.664B |
| July 09, 2026 | 10.66B |
| July 08, 2026 | 14.01B |
| July 07, 2026 | 14.32B |
| July 06, 2026 | 13.80B |
| July 02, 2026 | 13.57B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 33.26B |
| Biogen, Inc. | 32.07B |
| BridgeBio Pharma, Inc. | 14.15B |
| Vertex Pharmaceuticals, Inc. | 130.59B |
| Arrowhead Pharmaceuticals, Inc. | 11.69B |
Market Cap Related Metrics
| PS Ratio | 10.11 |
| PEG Ratio | -0.1783 |
| Price to Book Value | 20.42 |
| Price | 54.21 |
| Earnings Yield | -6.41% |
| PEGY Ratio | -0.1783 |